Health In Tech Inc（HIT）财务数据HITHealth In Tech Inc

Evaluating the bottom line, Health In Tech Inc maintains a gross margin of 48.69%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -42.68%, while the net margin is -31.17%. These profitability ratios, combined with a Return on Equity (ROE) of -21.96%, provide a clear picture of how effectively HIT converts its operational activities into shareholder value.

In the context of the broader market, HIT competes directly with industry leaders such as AURE and XTIA. With a market capitalization of $34.20M, it holds a significant position in the sector. When comparing efficiency, HIT's gross margin of 48.69% stands against AURE's N/A and XTIA's 17.39%. Such benchmarking helps identify whether Health In Tech Inc is trading at a premium or discount relative to its financial performance.

The company reported a gross margin of 48.69% in Q2 2026, which, while declining, still reflects a solid profit structure. Total revenue for Q2 was $8.1 million, down 13.5% year-over-year, but contracted revenue of $32.3 million for the first half of 2026 shows potential for future growth.